Elena Dale
About Elena Dale
Elena Dale serves as the Senior Director and Head of CNS Biology at Wave Life Sciences, where she has worked since 2019. She holds advanced degrees in Physiology and Neuroscience from New York University School of Medicine and has extensive expertise in various CNS indications.
Work at Wave Life Sciences
Elena Dale has served as the Senior Director and Head of CNS Biology at Wave Life Sciences since 2019. In this role, she leads initiatives focused on central nervous system (CNS) biology, overseeing a range of projects that span from target identification to lead optimization and non-GLP toxicology studies. Her leadership is integral to the company's efforts in advancing therapies for various CNS indications.
Education and Expertise
Elena Dale holds a Doctor of Philosophy in Physiology and Neuroscience from New York University School of Medicine, where she also earned a Master of Science. She completed her undergraduate studies at Boston University, obtaining a Bachelor of Science in Biology. Her academic background provides a strong foundation for her extensive expertise in CNS indications, including depression, schizophrenia, Parkinson's disease, Alzheimer's disease, epilepsy, ADHD, and pain.
Background
Elena Dale has a comprehensive background in neuroscience and drug discovery. She has managed collaborations with academic institutions and contract research organizations (CROs), enhancing the research capabilities and project outcomes in her field. Her experience includes leading diverse project teams, which has contributed to her successful track record in the industry.
Achievements in Neuroscience Publications
Elena Dale has co-authored 31 peer-reviewed publications in neuroscience, with 17 of these focused specifically on drug discovery studies or review articles in the past five years. This body of work reflects her active engagement in advancing knowledge in the field and her contributions to the scientific community.
Knowledge in Drug Discovery and Pharmacology
Elena Dale possesses in-depth knowledge of drug discovery processes, electrophysiology, and pharmacology. Her expertise in these areas supports her role in developing innovative therapies for CNS disorders, contributing to the advancement of treatment options for patients.